Critical Care Management for Novel 2019 SARS-CoV-2 and HCoV-NL63 Coinfection in a Young Immunocompromised Patient: A Chicago Experience
Background. SARS-CoV-2 is a newly emerged virus that has spread rapidly, exhibiting tremendous morbidity and mortality. Some potential pharmaceutical targets have been identified but are still lacking proper validation. Case Presentation. We describe the case of a young, immunosuppressed and critica...
Saved in:
Main Authors: | Alejandro Sanchez-Nadales, Miguel Treminio-Quezada, Hasan Abad, Jessica Navarro-Motta, Pamela Contreras-Chavez, Anil Kachru, Chae Chu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Critical Care |
Online Access: | http://dx.doi.org/10.1155/2020/8877641 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of Primer Panels for Whole-Genome Amplification and Sequencing of Human Seasonal Coronaviruses: hCoV-OC43, hCoV-HKU1, hCoV-229E, and hCoV-NL63
by: Tamila Musaeva, et al.
Published: (2024-12-01) -
Pre-existing IgG antibodies to HCoVs NL63 and OC43 Spike increased during the pandemic and after COVID-19 vaccination
by: Zahra Hasan, et al.
Published: (2025-02-01) -
The transcriptional and translational landscape of HCoV-OC43 infection.
by: Stefan Bresson, et al.
Published: (2025-01-01) -
HCoV‐HKU1 and TMPRSS2 interaction: uncovering mechanisms of viral invasion
by: Zehan Pang, et al.
Published: (2025-01-01) -
Co-infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and human coronavirus HKU1 (HCoV-HKU1)
by: Laszlo Madaras, et al.
Published: (2025-01-01)